Royal Caribbean CEO: Future's Never Looked So Bright
Royal Caribbean CEO Richard Fain says millennials are the fastest-growing consumer for the cruise line. He tells us they are looking to travel with Royal Caribbean to create experiences. One way the company is specifically courting consumers is through virtual reality.
Despite hits to service from hurricanes, Royal Caribbean posted record quarterly earnings this week.
It generated $2.57 billion in revenue, slightly missing analyst expectations of $2.58 billion. Notably, net yields were up 5.3 percent year-over-year. Shares of Royal Caribbean are up 55 percent year-to-date.
As part of Cheddar's special hour dedicated to entrepreneurs and their secrets to success with #MakeCheddar, Cheddar Anchor Kori Hale asked Fain's advice to those thinking about switching careers to #MakeCheddar. He said, "Follow your own mantra."
Former Medtronic CEO and author of 'True North' Bill George explains the steps Boeing leadership must take to regain client and consumer trust after 737 Max 9 production was stopped.
Amazon blamed "regulatory hurdles" for calling off its proposed acquisition of robot vacuum maker iRobot. Not even a Roomba could clean up the deal's antitrust scrutiny.
To celebrate Flutter Entertainment's debut on the NYSE, FanDuel CEO Amy Howe shares her thoughts on the company's plans for growth, the future of online sportsbetting, and Super Bowl Sunday.
Investopedia's Caleb Silver shares thoughts on the upcoming Fed meeting, why individual investors are still slightly skeptical, and what he's looking for from mega cap tech earnings.
Season's greetings! Tax season, that is. January 29 is the first day you can file your tax return. We walk you through each step — plus a checklist you can download.
The Q-Collar helps protect athletes from impact-related concussions. Now, the U.S. Army is evaluating if the device could help reduce traumatic brain injury cased by blast weapons.
Co-founder and executive chairman of the board at Vaxxinity Lou Reese shares how the company is working to bring vaccines for chronic illnesses like heart disease and Parkinson’s to market with an eye for accessibility.
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
